Leap Therapeutics Inc (LPTX)
2.88
-0.12
(-3.84%)
USD |
NASDAQ |
Nov 14, 16:00
2.95
+0.07
(+2.43%)
After-Hours: 18:45
Leap Therapeutics Total Assets (Quarterly): 81.43M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 81.43M |
| March 31, 2024 | 57.96M |
| December 31, 2023 | 72.82M |
| September 30, 2023 | 83.05M |
| June 30, 2023 | 95.86M |
| March 31, 2023 | 106.55M |
| December 31, 2022 | 70.35M |
| September 30, 2022 | 82.16M |
| June 30, 2022 | 94.20M |
| March 31, 2022 | 105.90M |
| December 31, 2021 | 117.91M |
| September 30, 2021 | 128.08M |
| June 30, 2021 | 37.94M |
| March 31, 2021 | 45.81M |
| December 31, 2020 | 54.37M |
| September 30, 2020 | 60.54M |
| June 30, 2020 | 67.67M |
| March 31, 2020 | 28.74M |
| December 31, 2019 | 7.448M |
| September 30, 2019 | 14.14M |
| June 30, 2019 | 20.14M |
| Date | Value |
|---|---|
| March 31, 2019 | 26.08M |
| December 31, 2018 | 19.07M |
| September 30, 2018 | 27.13M |
| June 30, 2018 | 34.41M |
| March 31, 2018 | 38.69M |
| December 31, 2017 | 29.06M |
| September 30, 2017 | 17.58M |
| June 30, 2017 | 22.73M |
| March 31, 2017 | 28.78M |
| December 31, 2016 | 6.457M |
| June 30, 2016 | 25.62M |
| December 31, 2015 | 1.26M |
| September 30, 2015 | 31.43M |
| June 30, 2015 | 36.72M |
| March 31, 2015 | 42.72M |
| December 31, 2014 | 48.70M |
| September 30, 2014 | 55.36M |
| June 30, 2014 | 14.72M |
| March 31, 2014 | 18.22M |
| December 31, 2013 | 20.74M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
7.448M
Minimum
Dec 2019
128.08M
Maximum
Sep 2021
73.62M
Average
72.82M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 15.72M |
| Perspective Therapeutics Inc | 385.92M |
| Protalix BioTherapeutics Inc | 91.54M |
| Electromed Inc | 52.23M |
| Armata Pharmaceuticals Inc | 108.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.64M |
| Shareholders Equity (Quarterly) | 65.79M |